These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38184120)

  • 1. Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells.
    Zhou W; Lim A; Elmadbouh OHM; Edderkaoui M; Osipov A; Mathison AJ; Urrutia R; Liu T; Wang Q; Pandol SJ
    Free Radic Biol Med; 2024 Feb; 212():493-504. PubMed ID: 38184120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verteporfin Exerts Anticancer Effects and Reverses Resistance to Paclitaxel via Inducing Ferroptosis in Esophageal Squamous Cell Cancer Cells.
    Wang XW; Yang ZY; Li T; Zhao XR; Li XZ; Wang XX
    Mol Biotechnol; 2023 Sep; ():. PubMed ID: 37751128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex.
    Wei H; Wang F; Wang Y; Li T; Xiu P; Zhong J; Sun X; Li J
    Cancer Sci; 2017 Mar; 108(3):478-487. PubMed ID: 28002618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma.
    Yang C; Dong Q; Bao H; Ge Y; Xu Z; Li J; Jiang X; Xu Y; Zhong X
    Front Biosci (Landmark Ed); 2024 Jan; 29(1):45. PubMed ID: 38287825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer.
    Zhao X; Wang X; Fang L; Lan C; Zheng X; Wang Y; Zhang Y; Han X; Liu S; Cheng K; Zhao Y; Shi J; Guo J; Hao J; Ren H; Nie G
    Cancer Lett; 2017 Aug; 402():61-70. PubMed ID: 28576749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Hippo/YAP signaling pathway ameliorates cochlear hair cell injury by regulating ferroptosis.
    Niu X; Han P; Liu J; Chen Z; Ma X; Zhang T; Li B; Ma X
    Tissue Cell; 2023 Jun; 82():102051. PubMed ID: 36889225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of YAP suppresses cell proliferation and elevates the sensitivity of chemotherapy in retinoblastoma cells through lipid-peroxidation induced ferroptosis.
    Zhong L; Meng X; Huang J; Hao W; Zuo Y
    Chin Clin Oncol; 2023 Oct; 12(5):52. PubMed ID: 37964544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
    Du J; Wang X; Li Y; Ren X; Zhou Y; Hu W; Zhou C; Jing Q; Yang C; Wang L; Li H; Fang L; Zhou Y; Tong X; Wang Y
    Cell Death Dis; 2021 Jul; 12(7):705. PubMed ID: 34262021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PITX2 functions as a transcription factor for GPX4 and protects pancreatic cancer cells from ferroptosis.
    Wang Z; Wu D; Zhang Y; Chen W; Yang Y; Yang Y; Zu G; An Y; Yu X; Qin Y; Xu X; Chen X
    Exp Cell Res; 2024 Jun; 439(1):114074. PubMed ID: 38710403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation.
    Brodowska K; Al-Moujahed A; Marmalidou A; Meyer Zu Horste M; Cichy J; Miller JW; Gragoudas E; Vavvas DG
    Exp Eye Res; 2014 Jul; 124():67-73. PubMed ID: 24837142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis Induction and YAP Inhibition as New Therapeutic Targets in Gastrointestinal Stromal Tumors (GISTs).
    Delvaux M; Hagué P; Craciun L; Wozniak A; Demetter P; Schöffski P; Erneux C; Vanderwinden JM
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verteporfin inhibits cell proliferation and induces apoptosis in different subtypes of breast cancer cell lines without light activation.
    Wei C; Li X
    BMC Cancer; 2020 Oct; 20(1):1042. PubMed ID: 33121449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
    Li T; Guo T; Liu H; Jiang H; Wang Y
    Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor.
    Wei C; Li X
    Front Pharmacol; 2020; 11():557429. PubMed ID: 33178014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the migration effect and molecular docking of verteporfin in different subtypes of breast cancer cells.
    Wei C; Li X
    Mol Med Rep; 2020 Nov; 22(5):3955-3961. PubMed ID: 32901856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch3 regulates ferroptosis via ROS-induced lipid peroxidation in NSCLC cells.
    Li Z; Xiao J; Liu M; Cui J; Lian B; Sun Y; Li C
    FEBS Open Bio; 2022 Jun; 12(6):1197-1205. PubMed ID: 35258176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Potential Mechanism and Therapeutic Target of Ferroptosis in PDAC: A Promising Future.
    Li C; Yin X; Liu Z; Wang J
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway.
    Dong L; Lin F; Wu W; Liu Y; Huang W
    Int J Med Sci; 2018; 15(6):645-652. PubMed ID: 29725256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines".
    Sanna L; Piredda R; Marchesi I; Bordoni V; Forcales SV; Calvisi DF; Bagella L
    Chem Biol Interact; 2019 Oct; 312():108813. PubMed ID: 31494105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Molecule-Targeted Therapy and Photodynamic Therapy Using Nanoformulated Verteporfin for Effective Uveal Melanoma Treatment.
    Song M; Zhu L; Zhang L; Ge X; Cao J; Teng Y; Tian R
    Mol Pharm; 2024 May; 21(5):2340-2350. PubMed ID: 38546166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.